Cargando…
Revisiting Pituitary Apoplexy
Pituitary apoplexy (PA) is a rare clinical syndrome due to pituitary hemorrhage or infarction. It is characterized by the sudden onset of one or more of the following: severe headache, visual disturbance, nausea/vomiting, and or altered mental status. Most commonly, PA occurs in an underlying pituit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342855/ https://www.ncbi.nlm.nih.gov/pubmed/35928242 http://dx.doi.org/10.1210/jendso/bvac113 |
_version_ | 1784760909760036864 |
---|---|
author | Donegan, Diane Erickson, Dana |
author_facet | Donegan, Diane Erickson, Dana |
author_sort | Donegan, Diane |
collection | PubMed |
description | Pituitary apoplexy (PA) is a rare clinical syndrome due to pituitary hemorrhage or infarction. It is characterized by the sudden onset of one or more of the following: severe headache, visual disturbance, nausea/vomiting, and or altered mental status. Most commonly, PA occurs in an underlying pituitary adenoma. The pathophysiology is not fully understood, but it is thought to involve elements of increased metabolic demand and/or compromise to the vasculature of the pituitary or pituitary tumor. Several risk factors have been described. Stabilization of the patient on presentation, replacement of hormonal deficiencies, and reversal of electrolyte abnormalities are the recommended initial steps in the management of patients with PA. Surgical decompression of the mass effect had been the recommended treatment for patients with PA; however, retrospective studies of patients with PA have demonstrated similar outcomes when a conservative approach is applied. This suggests that in highly selected clinical scenarios (mild visual deficit and improving symptoms), conservative management is possible. Further studies, however, are necessary to better stratify patients but are limited by the rarity of the condition and the acuity. |
format | Online Article Text |
id | pubmed-9342855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93428552022-08-03 Revisiting Pituitary Apoplexy Donegan, Diane Erickson, Dana J Endocr Soc Mini-Review Pituitary apoplexy (PA) is a rare clinical syndrome due to pituitary hemorrhage or infarction. It is characterized by the sudden onset of one or more of the following: severe headache, visual disturbance, nausea/vomiting, and or altered mental status. Most commonly, PA occurs in an underlying pituitary adenoma. The pathophysiology is not fully understood, but it is thought to involve elements of increased metabolic demand and/or compromise to the vasculature of the pituitary or pituitary tumor. Several risk factors have been described. Stabilization of the patient on presentation, replacement of hormonal deficiencies, and reversal of electrolyte abnormalities are the recommended initial steps in the management of patients with PA. Surgical decompression of the mass effect had been the recommended treatment for patients with PA; however, retrospective studies of patients with PA have demonstrated similar outcomes when a conservative approach is applied. This suggests that in highly selected clinical scenarios (mild visual deficit and improving symptoms), conservative management is possible. Further studies, however, are necessary to better stratify patients but are limited by the rarity of the condition and the acuity. Oxford University Press 2022-07-26 /pmc/articles/PMC9342855/ /pubmed/35928242 http://dx.doi.org/10.1210/jendso/bvac113 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Mini-Review Donegan, Diane Erickson, Dana Revisiting Pituitary Apoplexy |
title | Revisiting Pituitary Apoplexy |
title_full | Revisiting Pituitary Apoplexy |
title_fullStr | Revisiting Pituitary Apoplexy |
title_full_unstemmed | Revisiting Pituitary Apoplexy |
title_short | Revisiting Pituitary Apoplexy |
title_sort | revisiting pituitary apoplexy |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342855/ https://www.ncbi.nlm.nih.gov/pubmed/35928242 http://dx.doi.org/10.1210/jendso/bvac113 |
work_keys_str_mv | AT donegandiane revisitingpituitaryapoplexy AT ericksondana revisitingpituitaryapoplexy |